Business Wire

Profen to Deliver High Performance Networks across Türkiye and beyond with SES’s O3b mPOWER system

Share

The energy companies, government agencies, the telco companies and humanitarian aid organisations in Türkiye, the Middle East and Africa will soon be able to access high-performance, low-latency satellite-based connectivity services, Profen and SES announced today.

The combined capacity and infrastructure agreements will see Profen, the global high-tech solutions company, deploy SES’s second-generation medium earth orbit (MEO) system – O3b mPOWER – and build a gateway in Türkiye to jointly deliver high-performance connectivity to serve identified market opportunities of more than 10 Gbps.

By installing the O3b mPOWER gateway at the core of its networks, Profen’s customers in industries such as telecommunications, energy and humanitarian aid organisations can roll-out more secure networks and minimise latency by reducing the required hops between endpoints. In addition, Profen will be providing a range of services such as mobile backhaul, disaster recovery and private 5G, enabling local companies and neighboring ones in Europe, the Middle East, Africa and central Asia to enjoy the services that are backed by robust service level agreements.

The partnership is designed to enhance the digital infrastructure and broadband services of the region. According to data from the International Telecommunication Union, Türkiye has more than 71 million internet users for a penetration rate of 83%. The same research also shows that while there are plans to deploy 5G networks across the country, today almost 82 million cellular mobile connections are still on 3G and 4G networks in 2023. The partnership between Profen and SES will not only boost digital infrastructure and broadband services but enable both companies to provide connectivity solutions to various market segments, ultimately resulting in improved network coverage, faster speeds, low-latency and enhanced reliability and security.

“The launch of the O3b mPOWER system represents a significant milestone for the satcom industry, and we are proud to be at the forefront of this technological revolution. As a leading provider of high-tech solutions, Profen is committed to delivering innovative and reliable connectivity services to our customers. With the deployment of SES’s O3b mPOWER gateway in Türkiye, we are excited to offer our customers on land, out at sea or in the skies unprecedented access to high-performance, low-latency satellite-based connectivity services.” said Cem Odaman, Chief Business Development Officer at Profen.

“We are very excited to partner with Profen and to jointly introduce high-throughput and low-latency satellite-enabled services to Türkiye and surrounding regions. With O3b mPOWER, Profen will have access to a reliable and high-speed network, whenever and wherever they need it, allowing them to quickly and flexibly address the changing connectivity demands of their customers, including the highly anticipated 5G technology,” said Brendan O’Callaghan, Global Head of Enterprise and Cloud at SES.

Two launches have already taken place in December 2022 and April 2023, with a third and final launch of two additional satellites still to come, bringing the total number of satellites to six. The system is expected to be operational by the third quarter of 2023, enabling companies and organisations to benefit from high-performance network services offering industry-best throughput, predictable low latency, and ultra-reliable service availability.

For more information on how O3b mPOWER can bring a new level of performance to satellite-enabled communications, visit the newsroom.

Follow us on:

Twitter | Facebook | YouTube | LinkedIn | Instagram

Read our Blogs >

Visit the Media Gallery >

About SES

SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world. As the leader in global content connectivity solutions, SES operates the world’s only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system. By leveraging a vast and intelligent, cloud-enabled network, SES is able to deliver high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries ~8,000 channels and has an unparalleled reach of 369 million households, delivering managed media services for both linear and non-linear content. The company is listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com.

About Profen

Founded in 1995, Profen is a leading player in the global communications technologies market. With its own research and development center and offices in Istanbul, Ankara, Konya, Tewkesbury (UK), and Baku (Azerbaijan), Profen has been providing cutting-edge solutions to customers around the world for more than 28 years.

Profen offers top-notch satellite communication services to the partners and clients worldwide. Profen strengthens its services via privately owned and operated Data Centers and Ground Stations in Konya and Ankara locations. Profen’s multiple locations in Turkey ensure company’s position to meet various needs coming from the clients and partners while giving the most reliable and sustainable services possible. In the time where uninterrupted communication is essential, our multiple data centers and ground stations have become a prominent instrument for increased availability, disaster recovery and improved scalability.

Profen has the unique capability to design, manufacture and provide engineering services with satellite background and implement turn-key solutions for its clients while combining different technologies and disciplines.

Learn more about Profen: www.profen.com

Follow Profen on:

LinkedIn | Instagram | YouTube | Twitter

Read our Blogs >

Visit the Media Center >

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For further information please contact:

Suzanne Ong
External Communications
Tel. +352 710 725 500
suzanne.ong@ses.com

Gamze Seringen
Marketing Communications
Tel. +90 212 939 14 71
gamze.seringen@profen.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Interactive Brokers Launches Daily Options on the CAC 40® Index2.5.2024 17:00:00 EEST | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker, today announced the availability of Daily Options on the CAC 40® index, further expanding Interactive Brokers’ robust product suite. Daily Options on the CAC 40® index provide experienced investors with another means to execute short-term trading strategies and manage exposure to the French stock market. Milan Galik, Chief Executive Officer of Interactive Brokers, commented on the launch, "We are pleased to offer Daily Options on the CAC 40® index, which will allow our clients to balance risk and swiftly adjust their portfolios in response to market movements. At Interactive Brokers, we strive to equip our clients with an array of products to find global opportunities, and this new offering underscores our commitment to providing traders with comprehensive product solutions.” Daily Options on the CAC 40® index cater to growing demand from institutional and retail investors for options with daily expirations. The

AMRA Medical’s Muscle Composition Analysis Used to Evaluate the Effect of Liraglutide Treatment in Obesity2.5.2024 16:35:00 EEST | Press release

AMRA Medical - a health informatics and precision medicine company that is pioneering body composition research through gold-standard MRI-based analysis platforms - collaborated on a study driven by University of Texas Southwestern and University Hospital Cleveland to publish new data revealing the effect of liraglutide treatment on muscle composition in adults with obesity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240502719692/en/ Credit: Collaboration with Dr. Ian J Neeland, University Hospitals Cleveland. Data from NCT03038620 (ClinicalTrials.gov identifier) analysed with AMRA® Researcher The analysis included 128 diabetes-free adults with obesity who received a lifestyle intervention in addition to being randomized to either a liraglutide (n = 73) or a placebo (n = 55) treatment group. Using the proprietary MRI-based AMRAⓇ Researcher, baseline and follow-up muscle composition analyses were performed, with the prima

Brightcove Integrates New AWS-Powered Generative AI Solution to Enhance Its Award-Winning Customer Service2.5.2024 16:00:00 EEST | Press release

Brightcove (NASDAQ: BCOV), the world’s most trusted streaming technology company, today shared it has implemented Amazon Q Business, a new generative AI assistant on Amazon Web Services (AWS). Using its own public documentation, product, and release notes, Brightcove is leveraging the new assistant internally for real-world use cases applicable to the media and entertainment technology sector. Brightcove is tapping into the technology to build a program to equip its global services and customer success team to further bolster its award-winning customer service. As an early adopter of Amazon Q, Brightcove has launched the “Brightcove Expert Bot,” an AI-powered chatbot embedded into the internal tools, as a new resource for the customer and product support teams. Streamlining its customer support processes enables employees to quickly and effectively find relevant information, solve technical cases, analyze support requests, summarize support tickets, and use those results to help recomm

Power2Drive Europe: Contributing to the Energy Transition With Bidirectional Charging2.5.2024 15:39:00 EEST | Press release

E-mobility is about much more than driving on climate-neutral electricity from renewable sources. The batteries of electric vehicles can be used as temporary storage. And it’s not just vehicle owners who benefit from this: In the medium-term, bidirectional charging can take the burden off distribution grids while making them more flexible. Power2Drive Europe, the international exhibition for charging infrastructure and e-mobility, showcases the latest state of the art. As part of The smarter E Europe, the continent’s largest alliance of exhibitions for the energy industry, it will take place from June 19–21, 2024, at Messe München. The Power2Drive Europe Conference, the industry's meeting point and forum for exchange and discourse among experts, stakeholders, and thought leaders in the new mobility sector, kicks off one day earlier. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240502196803/en/ Power2Drive Europe 2024 highl

Owlet Announces European Medical Certification of Dream SockⓇ2.5.2024 15:37:00 EEST | Press release

Owlet, Inc. (“Owlet” or the “Company”) (NYSE:OWLT), the pioneer of smart infant monitoring, announces the EU medical device certification of Dream Sock. This EU-CE-Mark certification, issued by Owlet’s EU notified body, signifies that Owlet’s Dream Sock has been assessed and certified to meet safety and health requirements set out under EU medical device legislation. With this certification, Owlet plans to expand its medical-device product portfolio to even more caregivers around the world. This EU medical device certification follows two marketing authorizations from the U.S. Food and Drug Administration (the “FDA”), for Dream Sock, with new medical technology for healthy infants over-the-counter without a prescription, and for BabySat Ⓡ, a prescription-only pulse oximeter designed for use with babies that have a pre-existing medical condition. “Our mission to be there for every parent and every baby becomes even more realized with the European medical certification for Dream Sock,” s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye